Table 2.
Placebo (group I, n=30) | NAC (group II, n=30) | P | |
---|---|---|---|
Plasma creatinine levels of ≥1.5 mg/dL or >25% of baseline, % | 37 | 27 | 0.049 |
Serum NGAL levels of >149 ng/mL, % | 4.17 | 0.83 | 0.099 |
Renal replacement therapy, % | 3.33 | 0.00 | 0.321 |
Placebo (group I, n=30) | NAC (group II, n=30) | P | |
---|---|---|---|
Plasma creatinine levels of ≥1.5 mg/dL or >25% of baseline, % | 37 | 27 | 0.049 |
Serum NGAL levels of >149 ng/mL, % | 4.17 | 0.83 | 0.099 |
Renal replacement therapy, % | 3.33 | 0.00 | 0.321 |